Should we debulk the primary tumor in some men with metastatic prostate cancer?

Back in the 1980s, it would never (well, probably nearly never) have crossed anyone’s mind to carry out any type of primary tumor-debulking treatment on any patient who was newly diagnosed with evident, metastatic prostate cancer. … READ MORE …

Risk for conversion from minimally invasive to open surgery for prostate cancer patients

A new paper in the Journal of Urology provides us with a detailed assessment of the likelihood of and the risks associated with the need to convert from a minimally invasive (e.g., robot-assisted) to an open surgical procedure during the course of a radical prostatectomy. … READ MORE …

Which patients with a PSM post-surgery need early adjuvant therapy?

Could more intensive monitoring of PSA levels in the first few months after a radical prostatectomy help to determine which patients who have a positive surgical margin (PSM) need adjuvant radiation therapy and which don’t? … READ MORE …

Long-term impact on workplace status after radical prostatectomy

A recent Norwegian study has concluded that pre-surgical counseling of men electing treatment for prostate cancer by radical prostatectomy needs to include advice about risk for the possibility of post-surgical issues that may affect work status and their working life 3 years after their surgery. … READ MORE …

Serum lipid levels and post-surgical risk for prostate cancer recurrence

According to an article published today in Cancer Epidemiology, Biomarkers and Prevention, men with dyslipidemia (an abnormal lipid profile) and elevated total cholesterol levels who have surgery for prostate cancer are at significantly increased risk for prostate cancer recurrence. … READ MORE …

“There’s a sponge in my prostate, dear doctor, dear doctor”

About once in every 5,500 to 7,000 surgical operations carried out in hospitals around America each year, “something” gets left behind in a patient … and that “something” is most likely to be one of those small surgical sponges used to mop up excess blood or other fluids during the course of the operation. … READ MORE …

Baseline data from the ProtecT trial … with outcomes still to come

Many readers of this blog will be interested to look through the data on the preliminary study design and diagnostic and baseline results of the randomized, phase III ProtecT trial that have just been reported in The Lancet Oncology. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,169 other followers